Open Access Pub publishes peer-reviewed, free-to-read open-access articles. Showing
articles matching Proteomics — open any to read the full text,
or download the PDF or XML.
Jan 2014 DOI 10.14302/issn.2326-0793.jpgr-13-357
Emily I. ChenCorresponding author
Mass spectrometry (MS) has been successfully used to analyze biological samples and advances of MS-based approaches have turn MS data from largely qualitative to quantitative. These MS-based quantitative approaches using label-free, tags, or stable isotope labeling have their own strengths and limit…
Jan 2014 DOI 10.14302/issn.2326-0793.jpgr-sp1-edt-1
Leonid TarassishinCorresponding author
A primer explains how proteomics scales from single‑protein analysis to whole‑organism studies, touching on technologies, bioinformatics, and applications.
Jan 2014 DOI 10.14302/issn.2326-0793.jpgr-13-sicover
Leonid TarassishinCorresponding author
Sep 2013 DOI 10.14302/issn.2326-0793.jpgr-13-257
Kathleen O’ConnellCorresponding author
Lapatinib, a small molecule tyrosine kinase inhibitor is currently used in the treatment of HER2-positive breast cancer. The aim of this study was to further understanding of lapatinib response for the development of novel treatment lapatinib-focussed treatment strategies. HER2-overexpressing SKBR3…
Jul 2013 DOI 10.14302/issn.2326-0793.jpgr-13-252
Emily I. ChenCorresponding author
In biomedical research the use of mammalian tissues is crucial to increase our understanding of complex human diseases. Mass spectrometry-based proteomic approach has become the most powerful tool of studying large-scale protein expression profiles in mammalian tissues. To perform global proteome an…
Jul 2013 DOI 10.14302/issn.2326-0793.jpgr-12-edt-1.2
Leonid TarassishinCorresponding author
An editorial for the second issue highlights notable contributions and reaffirms peer review and openness as pillars for the field.
Dec 2012 DOI 10.14302/issn.2326-0793.jpgr-12-edt-1.1
Diana M. GilliganCorresponding author
An editorial announcing the journal’s launch sets expectations for data standards, reproducibility, and integrative omics studies with clinical relevance.
Nov 2025 DOI 10.14302/issn.2326-0793.jpgr-25-5573
Oghenetega E. ImiruayeCorresponding author
Advancements in proteomic and genomic technologies have transformed molecular biology by enabling comprehensive analysis of biological systems at the molecular level. This literature review explores the evolution, methodologies, and practical applications of key proteomic and genomic techniques. In…
Feb 2025 DOI 10.14302/issn.2326-0793.jpgr-25-5405
Ming-Fen HoCorresponding author
Alcohol use disorder (AUD) is the most prevalent substance use disorder. Excessive alcohol consumption leads to a range of health issues. We set out to identify inflammatory markers linked to alcohol consumption, which might ultimately offer novel insight into genetic underpinnings and have implicat…
Aug 2018 DOI 10.14302/issn.2576-6694.jbbs-18-2173
Nida Tabassum KhanCorresponding author
Bioinformatic tools is widely used to manage the enormous genomic and proteomic data involving DNA/protein sequences management, drug designing, homology modelling, motif/domain prediction ,docking, annotation and dynamic simulation etc. Bioinformatics offers a wide range of applications in numerous…
Mar 2018
Xiaoping LiuCorresponding author
An important use of proteomics data from Mass Spectrometry (MS) is the classification of tumor types with respect to peptides in specific cancer types. It is highly critical to find an optimal set of markers among specific cancer peptides whose expression can be clinically utilized to build assays f…